unknown
Stage
2
Investors
About
Capnia develops the CoSense® ETCOc Monitor, a non-invasive diagnostic device that measures end-tidal carbon monoxide in newborns' breath to detect and monitor hemolysis for improved jaundice management and reduced risk of bilirubin neurotoxicity.
Explore Capnia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.